Bergenbio ASA (BGBIO) — Financial Flexibility Index
Bergenbio ASA (BGBIO) has a Financial Flexibility Index of -4.63x as of December 2024. Free cash flow of Nkr-153.24 Million (operating CF Nkr-153.24 Million minus capex Nkr0.00) represents -5% of total liabilities (Nkr33.09 Million). Also explore net asset momentum of Bergenbio ASA to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Bergenbio ASA Financial Flexibility Index (2015–2024)
Historical Financial Flexibility Index trend for Bergenbio ASA across 10 annual periods. Check strategic asset allocation of Bergenbio ASA to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Bergenbio ASA (2015–2024)
Year-by-year free cash flow to debt coverage for Bergenbio ASA. For the full company profile including market capitalisation, see Bergenbio ASA market capitalisation.
| Year | Flexibility Index | Free Cash Flow (NOK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -4.63x | Nkr-153.24 Million | Nkr-153.24 Million | Nkr33.09 Million | ▲ +22.6% |
| 2023 | -5.99x | Nkr-280.50 Million | Nkr-280.50 Million | Nkr46.86 Million | ▼ -62.4% |
| 2022 | -3.69x | Nkr-288.23 Million | Nkr-288.23 Million | Nkr78.21 Million | ▲ +20.0% |
| 2021 | -4.61x | Nkr-303.34 Million | Nkr-303.34 Million | Nkr65.81 Million | ▼ -33.8% |
| 2020 | -3.45x | Nkr-234.22 Million | Nkr-234.29 Million | Nkr67.97 Million | ▲ +5.2% |
| 2019 | -3.64x | Nkr-184.08 Million | Nkr-184.15 Million | Nkr50.62 Million | ▲ +19.0% |
| 2018 | -4.49x | Nkr-186.48 Million | Nkr-186.71 Million | Nkr41.55 Million | ▲ +9.1% |
| 2017 | -4.94x | Nkr-167.77 Million | Nkr-168.11 Million | Nkr33.99 Million | ▲ +15.4% |
| 2016 | -5.83x | Nkr-124.06 Million | Nkr-124.31 Million | Nkr21.27 Million | ▼ -64.3% |
| 2015 | -3.55x | Nkr-62.65 Million | Nkr-62.90 Million | Nkr17.64 Million | — |